Peer Review reports
From: Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer
| Original Submission | ||
|---|---|---|
| 1 Nov 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 18 Dec 2022 | Reviewed | Reviewer Report - Eman S. El-shafey |
| 26 Dec 2022 | Reviewed | Reviewer Report |
| 12 Jan 2023 | Author responded | Author comments - Jieqing Li |
| Resubmission - Version 3 | ||
| 12 Jan 2023 | Submitted | Manuscript version 3 |
| 7 Feb 2023 | Author responded | Author comments - Jieqing Li |
| Resubmission - Version 4 | ||
| 7 Feb 2023 | Submitted | Manuscript version 4 |
| 9 Feb 2023 | Author responded | Author comments - Jieqing Li |
| Resubmission - Version 5 | ||
| 9 Feb 2023 | Submitted | Manuscript version 5 |
| 10 Feb 2023 | Author responded | Author comments - Jieqing Li |
| Resubmission - Version 6 | ||
| 10 Feb 2023 | Submitted | Manuscript version 6 |
| 23 Feb 2023 | Reviewed | Reviewer Report - Eman S. El-shafey |
| 17 Mar 2023 | Reviewed | Reviewer Report |
| 22 Mar 2023 | Author responded | Author comments - Jieqing Li |
| Resubmission - Version 7 | ||
| 22 Mar 2023 | Submitted | Manuscript version 7 |
| Publishing | ||
| 27 Mar 2023 | Editorially accepted | |
| 17 Apr 2023 | Article published | 10.1186/s12885-023-10774-w |
You can find further information about peer review here.